DXCM · News · 20261112N
Regulatory Approval Milestones
DEXCOM INC · 2026-11-12 · Importance 41 · Surprise 60
Health Canada approved Dexcom G7 for use with myLoop, powered by CamAPS FX, in an automated insulin delivery system for pregnant women with type 1 diabetes in Canada. The approval makes this the only AID system in Canada approved specifically for use during pregnancy. Reporting cited AiDAPT trial data showing improved time in pregnancy-specific glucose targets without added hypoglycemia risk. The approval establishes a pregnancy-specific clinical use case for Dexcom G7 within the myLoop ecosystem; the reports did not quantify its financial impact.
Key facts
- Health Canada approved use of the Dexcom G7 continuous glucose monitoring system within the myLoop automated insulin delivery setup for pregnancy. source
- Health Canada cleared Dexcom's G7 sensor for use with the myLoop system powered by CamAPS FX during pregnancy. source
- AiDAPT trial data supporting the pregnancy approval showed improved time in pregnancy-specific glucose targets without added hypoglycemia risk. source